JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB208097

Anti-KAT2A / GCN5 antibody [AT3G13]

Be the first to review this product! Submit a review

|

(6 Publications)

Knockout Tested Mouse Monoclonal KAT2A / GCN5 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Recombinant Fragment Protein within Human KAT2A aa 400-850.

View Alternative Names

GCN5, GCN5L2, KAT2A, Histone acetyltransferase KAT2A, General control of amino acid synthesis protein 5-like 2, Histone acetyltransferase GCN5, Histone glutaryltransferase KAT2A, Histone succinyltransferase KAT2A, Lysine acetyltransferase 2A, STAF97, hGCN5

3 Images
Immunocytochemistry/ Immunofluorescence - Anti-KAT2A / GCN5 antibody [AT3G13] (AB208097)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-KAT2A / GCN5 antibody [AT3G13] (AB208097)

Immunofluorescent analysis of HeLa cells labeling KAT2A / GCN5 with ab208097 at 1/500 dilution.

Western blot - Anti-KAT2A / GCN5 antibody [AT3G13] (AB208097)
  • WB

Lab

Western blot - Anti-KAT2A / GCN5 antibody [AT3G13] (AB208097)

Western blot : Anti-KAT2A antibody [AT3G13] (ab208097) staining at 1/1000 dilution, shown in green; Rabbit anti-alpha Tubulin antibody [EP1332Y] (ab52866) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab208097 was shown to bind specifically to KAT2A. A band was observed at 95 kDa in wild-type A549 cell lysates with no signal observed at this size in KAT2A knockout cell line. To generate this image, wild-type and KAT2A knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-KAT2A / GCN5 antibody [AT3G13] (ab208097) at 1/1000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

KAT2A knockout A549 cell lysate at 20 µg

Lane 3:

Wild-type U-2 OS cell lysate at 20 µg

Lane 4:

GCN5 knockout U-2 OS cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution

false

Western blot - Anti-KAT2A / GCN5 antibody [AT3G13] (AB208097)
  • WB

Supplier Data

Western blot - Anti-KAT2A / GCN5 antibody [AT3G13] (AB208097)

All lanes:

Western blot - Anti-KAT2A / GCN5 antibody [AT3G13] (ab208097) at 1/1000 dilution

All lanes:

HeLa cell lysate at 35 µg

Secondary

All lanes:

goat anti-mouse secondary antibody conjugated to HRP

Predicted band size: 94 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

AT3G13

Isotype

IgG2a

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

ICC/IF, WB

applications

Immunogen

Recombinant Fragment Protein within Human KAT2A aa 400-850. The exact immunogen used to generate this antibody is proprietary information.

Q92830

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/250 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250 - 1/500", "ICCIF-species-notes": "<p></p>" } } }

Product details

Derived from hybridization of mouse F0 myeloma cells.

This product was changed from ascites to tissue culture supernatant on 28/02/19. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 10% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

KAT2A also known as GCN5 is a lysine acetyltransferase enzyme with a molecular mass of approximately 92 kDa. It mainly acetylates histone proteins and affects transcriptional regulation by modifying chromatin structure. KAT2A/GCN5 is expressed in various tissues with significant expression in the nucleus of eukaryotic cells. Its role as a histone acetyltransferase places it as an important player in transcriptional activation by modifying the chromatin to a more open conformation facilitating access by transcription machinery.
Biological function summary

KAT2A/GCN5 participates in several cellular processes as part of larger protein complexes. It is a component of the SAGA (Spt-Ada-Gcn5 acetyltransferase) and TFTC (TBP-free TAF-containing complex) both involved in transcription regulation. Through these complexes KAT2A influences gene expression by acetylating histone residues which in turn affects the recruitment of other transcriptional activators or repressors. This activity also links it to non-histone substrates that support DNA damage repair and cellular senescence.

Pathways

KAT2A/GCN5 is integrally connected to the regulation of transcription and chromatin remodeling pathways. It interacts closely with the transcription factor c-Myc assisting in cell cycle regulation and proliferation. Additionally its presence in the p53 signaling pathway highlights its involvement in controlling cell growth and apoptosis. KAT2A/GCN5 activity influences downstream events in these pathways by affecting the acetylation state of specific histones and non-histone proteins.

The dysregulation of KAT2A/GCN5 is linked to cancer particularly in breast and colorectal cancers. Its role in acetylating key proteins like c-Myc and affecting pathways like p53 can lead to unchecked cell growth when improperly regulated. Furthermore KAT2A is connected to neurodegenerative diseases through its interactions with other histone modifiers such as HDAC1 and HDAC2 implicating it in conditions where neural cell function or maintenance goes awry.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Protein lysine acyltransferase that can act as a acetyltransferase, glutaryltransferase, succinyltransferase or malonyltransferase, depending on the context (PubMed : 29211711, PubMed : 35995428). Acts as a histone lysine succinyltransferase : catalyzes succinylation of histone H3 on 'Lys-79' (H3K79succ), with a maximum frequency around the transcription start sites of genes (PubMed : 29211711). Succinylation of histones gives a specific tag for epigenetic transcription activation (PubMed : 29211711). Association with the 2-oxoglutarate dehydrogenase complex, which provides succinyl-CoA, is required for histone succinylation (PubMed : 29211711). In different complexes, functions either as an acetyltransferase (HAT) or as a succinyltransferase : in the SAGA and ATAC complexes, acts as a histone acetyltransferase (PubMed : 17301242, PubMed : 19103755, PubMed : 29211711). Has significant histone acetyltransferase activity with core histones, but not with nucleosome core particles (PubMed : 17301242, PubMed : 19103755, PubMed : 21131905). Has a a strong preference for acetylation of H3 at 'Lys-9' (H3K9ac) (PubMed : 21131905). Acetylation of histones gives a specific tag for epigenetic transcription activation (PubMed : 17301242, PubMed : 19103755, PubMed : 29211711). Recruited by the XPC complex at promoters, where it specifically mediates acetylation of histone variant H2A.Z.1/H2A.Z, thereby promoting expression of target genes (PubMed : 29973595, PubMed : 31527837). Involved in long-term memory consolidation and synaptic plasticity : acts by promoting expression of a hippocampal gene expression network linked to neuroactive receptor signaling (By similarity). Acts as a positive regulator of T-cell activation : upon TCR stimulation, recruited to the IL2 promoter following interaction with NFATC2 and catalyzes acetylation of histone H3 at 'Lys-9' (H3K9ac), leading to promote IL2 expression (By similarity). Required for growth and differentiation of craniofacial cartilage and bone by regulating acetylation of histone H3 at 'Lys-9' (H3K9ac) (By similarity). Regulates embryonic stem cell (ESC) pluripotency and differentiation (By similarity). Also acetylates non-histone proteins, such as CEBPB, MRE11, PPARGC1A, PLK4 and TBX5 (PubMed : 16753578, PubMed : 17301242, PubMed : 27796307, PubMed : 29174768, PubMed : 38128537). Involved in heart and limb development by mediating acetylation of TBX5, acetylation regulating nucleocytoplasmic shuttling of TBX5 (PubMed : 29174768). Acts as a negative regulator of centrosome amplification by mediating acetylation of PLK4 (PubMed : 27796307). Acts as a negative regulator of gluconeogenesis by mediating acetylation and subsequent inactivation of PPARGC1A (PubMed : 16753578, PubMed : 23142079). Also acts as a histone glutaryltransferase : catalyzes glutarylation of histone H4 on 'Lys-91' (H4K91glu), a mark that destabilizes nucleosomes by promoting dissociation of the H2A-H2B dimers from nucleosomes (PubMed : 31542297).. (Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes.
See full target information KAT2A

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:2345 PubMed40057495

2025

GCN5-targeted dual-modal probe across the blood-brain barrier for borders display in invasive glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Haiyan Zheng,Lu Zhang,Xinning Bai,Jinchao Zhu,Shanshan Liu,Yao Ke,Qingyuan Lin,Yuan Yuan,Tianhai Ji

The Journal of biological chemistry 299:103020 PubMed36791914

2023

Histone acetyltransferase KAT2A modulates neural stem cell differentiation and proliferation by inducing degradation of the transcription factor PAX6.

Applications

Unspecified application

Species

Unspecified reactive species

Zhangji Dong,Wei He,Ge Lin,Xu Chen,Sixian Cao,Tuchen Guan,Ying Sun,Yufang Zhang,Mengwei Qi,Beibei Guo,Zhihao Zhou,Run Zhuo,Ronghua Wu,Mei Liu,Yan Liu

Clinical and translational medicine 12:e699 PubMed35184403

2022

Persistent high glucose induced EPB41L4A-AS1 inhibits glucose uptake via GCN5 mediating crotonylation and acetylation of histones and non-histones.

Applications

Unspecified application

Species

Unspecified reactive species

Weijie Liao,Naihan Xu,Haowei Zhang,Weifang Liao,Yanzhi Wang,Songmao Wang,Shikuan Zhang,Yuyang Jiang,Weidong Xie,Yaou Zhang

Scientific reports 10:2044 PubMed32029792

2020

Upregulation of GPNCA is associated with poor prognosis through enhancement of tumor growth via regulating GSK3B.

Applications

Unspecified application

Species

Unspecified reactive species

Weijie Liao,Fuhai Liu,Haowei Zhang,Weifang Liao,Naihan Xu,Weidong Xie,Yaou Zhang

Molecular psychiatry 24:1013-1026 PubMed30742007

2019

Early-life epigenetic changes along the corticotropin-releasing hormone (CRH) gene influence resilience or vulnerability to heat stress later in life.

Applications

Unspecified application

Species

Unspecified reactive species

Tomer Cramer,Tali Rosenberg,Tatiana Kisliouk,Noam Meiri

The Journal of biological chemistry 293:15947-15961 PubMed30158244

2018

Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Maša Ždralević,Almut Brand,Lorenza Di Ianni,Katja Dettmer,Jörg Reinders,Katrin Singer,Katrin Peter,Annette Schnell,Christina Bruss,Sonja-Maria Decking,Gudrun Koehl,Blanca Felipe-Abrio,Jérôme Durivault,Pascale Bayer,Marie Evangelista,Thomas O'Brien,Peter J Oefner,Kathrin Renner,Jacques Pouysségur,Marina Kreutz
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com